Matrix Biology of Idiopathic Pulmonary Fibrosis
Victor J. Thannickal(Pulmonary and Allergy Associates), Daniel J. Tschumperlin(Mayo Clinic in Florida), Rebecca G. Wells(University of Pennsylvania), Craig A. Henke(University of Minnesota), Eric S. White(University of Michigan–Ann Arbor), Paul W. Noble(Cedars-Sinai Medical Center), Yong Zhou(Tulane University), Jesse Roman(University of Louisville), Patricia J. Sime(University of Rochester), Jeffrey C. Horowitz(The Ohio State University Wexner Medical Center)
Cited by 116
Related Papers
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
|The Journal of Cell Biology|2010|811
Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.
|Journal of Clinical Investigation|1996|806
The myofibroblast matrix: implications for tissue repair and fibrosis
|The Journal of Pathology|2012|760